On the public citation graph

The Therapeutic Effect of Ofatumumab in Pediatric Anti-Nmdar Encephalitis: A Case Series

https://doi.org/10.2139/ssrn.4829109
0 signed · 20 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/bs.apha.2017.08.005openalex-extracted
Anti-NMDA Receptor Encephalitis: Clinical Features and Basic Mechanisms
inferredcites →https://doi.org/10.1016/j.jneuroim.2017.09.005openalex-extracted
Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes
inferredcites →https://doi.org/10.1016/j.jneuroim.2021.577479openalex-extracted
Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases
inferredcites →https://doi.org/10.1016/j.jneuroim.2021.577527openalex-extracted
Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study
inferredcites →https://doi.org/10.1016/j.jneuroim.2023.578062openalex-extracted
The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series
inferredcites →https://doi.org/10.1016/s1474-4422(10)70253-2openalex-extracted
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
inferredcites →https://doi.org/10.1016/s1474-4422(15)00401-9openalex-extracted
A clinical approach to diagnosis of autoimmune encephalitis
inferredcites →https://doi.org/10.1016/s1474-4422(19)30244-3openalex-extracted
An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models
inferredcites →https://doi.org/10.1056/nejmoa1917246openalex-extracted
Ofatumumab versus Teriflunomide in Multiple Sclerosis
inferredcites →https://doi.org/10.1111/ane.13291openalex-extracted
Efficacy and safety of rituximab in autoimmune encephalitis: A meta‐analysis
inferredcites →https://doi.org/10.1111/pcn.12821openalex-extracted
Recognizing psychiatric presentations of anti‐NMDA receptor encephalitis in children and adolescents: A synthesis of published reports
inferredcites →https://doi.org/10.1177/13524585221078825openalex-extracted
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
inferredcites →https://doi.org/10.1182/blood-2004-01-0039openalex-extracted
Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas
inferredcites →https://doi.org/10.1200/jco.2010.27.9836openalex-extracted
Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
inferredcites →https://doi.org/10.1212/wnl.0000000000003414openalex-extracted
NMDA receptor encephalitis and other antibody-mediated disorders of the synapse
inferredcites →https://doi.org/10.3389/fimmu.2017.01245openalex-extracted
Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
inferredcites →https://doi.org/10.3389/fimmu.2022.1064007openalex-extracted
Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis
inferredcites →https://doi.org/10.3389/fimmu.2022.840003openalex-extracted
Serum-Derived Exosomal miR-140-5p as a Promising Biomarker for Differential Diagnosis of Anti-NMDAR Encephalitis With Viral Encephalitis
inferredcites →https://doi.org/10.3389/fneur.2019.00906openalex-extracted
Pediatric Autoimmune Encephalitis: Case Series From Two Chinese Tertiary Pediatric Neurology Centers
inferredcites →https://doi.org/10.4103/aian.aian_236_23openalex-extracted
Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody, in the Treatment of Severe Refractory Anti-N-methyl-D-Aspartate Receptor Encephalitis: Two Case Reports
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.